At Cranfield we want to make sure that the outcomes of our research reach their full potential. If you are interested in how Cranfield’s innovative ideas and technology can boost your business, we would be delighted to talk to you.
Dedicated to solving real-life problems, we work in close collaboration with many organisations to turn ideas and innovation into reality. We pride ourselves on being flexible and entrepreneurial and have the capability to take a project from concept through to practical delivery.
The introduction of new technology can come with exciting commercial benefits as well as risks. To encourage your business to take on new ideas and innovations, our licensing terms are designed to inspire you to take this leap. During the process we will work closely with you to maximise success.
If you are seeking a particular technology or business solution, we will refer you to our Research & Innovation Office who will provide support to ensure a smooth, timely and successful transfer.
Some examples of our available technologies can be found below.
Robot Cleaning System
Design of an efficient and effective autonomous cleaning platform for public seating.
Researchers at Cranfield University have designed and tested an autonomous system that is capable of efficiently and effectively removing dirt and detritus from seats in public spaces. Example applications include trains, aeroplanes and theatres. The objective behind this technology is to reduce cleaning (turnaround) times in public facilities, as well as providing consistency and other performance improvements. A patent covering the robotic system has been filed and a prototype trialled by Cranfield University. The University is currently seeking development and licensing partners with whom to exploit the technology.
Slug Detection and Control System
A low-cost method of controlling slug flow, of a multi-phase fluid, in oil and gas wells.
The technology is an automated system and a method for controlling the two-phase liquid-gas flow in which the gas phase exists as large bubbles separated by liquid 'slugs', which can cause pressure oscillations within piping. The invention includes a riser pipe, choke valve and several sensors in the topside area. The sensors characterise fluid flow properties and estimate the formation of slug in the system. This technology allows the user to receive a data log from the sensors in the riser pipe and an estimate of the severity of the slug forming in the system. The technology was successfully tested within Schlumberger’s dynamic multiphase low simulator platform. A functional prototype was successfully tested on a live offshore oil production platform in the North Sea. The invention is patented and available for licensing.
Carbon Stabilisation Reactor (CSR)
A platform technology offering biogas pre-treatment from anaerobic digestion (AD), enhancing the operational efficiency of combined heat power (CHP) plants and minimising carbon footprint.
The technology is a pre-treatment device unit for controlling the CO2/CH4 ratio in biogas derived from AD. Synergy between AD and CHP is maximised when biogas is methane rich (ca. 65%). Biogas with a high proportion of CO2 lowers the burning velocity, reducing power output, CHP system profitability and return on investment while simultaneously increasing the concentrations of unburned fuel and greenhouse gases in exhaust emissions. The CSR device enables precise control of CO2/CH4 ratio through a unique phase separation and selective CO2 extraction technology, and can be easily integrated into existing biogas piping infrastructure, allowing for flexible biogas pre-treatment for the broad range of AD plants and processes, from smaller scale on-farm AD to wastewater treatment plants and all scales in between.
A priority patent application has been filed protecting the method to control the CO2/CH4 concentrations and its applications for biogas plants, and as a pre-treatment unit for CHP for the sustainable production of both thermal and electrical energy. Cranfield welcomes contact from parties interested in exploiting this opportunity.
Reflected Light Fluorescence - Direct Visual Observation (RLF-DVO)
Flow cell for on-line monitoring of membrane fouling.
A platform technology offering on-line monitoring of membrane fouling by sub-micron particles in membrane bioreactor (MBR), micro (MF), ultra (UF) and nano-filtration (NF) systems, reverse osmosis (RO) and non-membrane chemical water and wastewater treatment processes.
The technology consists of a flow cell system and a reflected light fluorescence visualisation method that enables non-invasive, on-line monitoring of membrane fouling and visualisation of the transport and deposition of sub-micron particles of biopolymers in the liquid flow and on the membrane surface. The RLF-DVO technology provides significant information on the fouling mechanism that can be used in process control for early detection and mitigation of membrane fouling to maximise operational and economic efficiency. The immediate application of the invention will be in MBR markets and microfiltration (MF) and ultrafiltration (UF) systems with a potential to be used in other membrane based markets including nanofiltration (NF) and reverse osmosis (RO) and non-membrane markets where chemical water and wastewater treatment is applied.
A priority patent application has been filed protecting the method and apparatus for monitoring membrane fouling and its applications in MBR systems. Cranfield welcomes contact from parties interested in exploiting this opportunity.
Bacterial Infection Marker Technology
A platform technology offering point-of-care, low-cost per test detection of bacterial infection in a portable device.
The technology is a device for early detection of bacterial infection in humans and the current prototype is being developed for clostridium difficile infection (CDI) detection application. CDI is an infection of the colon caused by the proliferation of the C. difficile bacteria, which produces harmful toxins that result in inflammation and manifests as severe diarrhoea. The target compound is p-cresol, which is related to C. difficile virulence but is but not tolerated by other bacteria. The device is designed for use in hospitals and other clinical environments with high risk of spread of bacterial infections, and can also be used in home care. The invention is subject to a PCT patent application, and is available for licensing and sponsored research support.
Cranfield supports investors keen to exploit our ideas and technologies through company formation.
We can support the formation of a spin out company if your research requires external investment to make it commercially viable. We also have business incubation facilities.
If you are in need of a new technology or require research to solve a business critical issue, please use the contact number above, or speak to our Research and Innovation Office.